Navigation Links
Replikins Oral Vaccine Synthesized in 7 Days Protects 91% of Shrimp Against a Lethal Virus
Date:3/11/2008

BOSTON, March 11 /PRNewswire/ -- Replikins, Ltd. has announced development of a chemically synthesized vaccine specific to a Taura Syndrome virus structure based on its patented Replikins(TM) technology. When the vaccine was administered orally to shrimp, 91% survived a challenge by the lethal Taura virus. The specificity of the protective effect was established in control groups by chemically blocking the active regions in the vaccine, and as a result the protective effect was lost in these control groups. The effectiveness of this vaccine, and its rapid production cycle (7 days), represent an important proof of concept for developing vaccines against a range of rapidly replicating high lethality virus outbreaks.

For counteracting emerging infectious disease, early detection and rapid response are critical. Replikin contributions to date are both in early detection and rapid response: 1) Advance warning previously was not possible until it was found in H5N1 influenza that an increase in the virus replikin concentration signalled one year in advance that the outbreak was coming, and indicated the country in which this would occur (FluForecast(TM), Indonesia). 2) The production of vaccines by other methods has required 3 to 12 months, by which time the epidemic may have come and gone, or the vaccine effectiveness reduced or lost because the target changed due to mutation. In contrast, the replikins vaccine found effective here was manufactured synthetically in 7 days.

Viruses lethal to shrimp have been responsible for large losses to aquaculture worldwide. Replikins is forming a division to focus on these viruses. The company is also pursuing development of synthetic vaccine products based on replikin epitopes, Syntopes(TM), for the control of fish hemorrhagic viruses and other lethal aquatic microorganisms,

Contact: Replikins Ltd., 38 The Fenway, Boston MA 02215. email: sbogoch@replikins.com Tel: 646-320-5910

SOURCE Replikins Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
2. Vaccinogens New Anti-Cancer Vaccine Commercially Available in Europe This Year
3. Childhood Influenza Immunization Coalition Applauds Expanded Influenza Vaccine Recommendation for Children
4. Combination vaccine protects monkeys from ebola and Marburg viruses
5. Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
6. Vaccines are Likely to Cause Insulin Dependent Diabetes in Over 2% of Children With a Strong Family History of Insulin Dependent Diabetes, New Data Indicates
7. GSK Receives Favorable Recommendation by FDA Advisory Committee for Rotarix(R) (Rotavirus Vaccine, Live, Oral)
8. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
9. Vaccinex Antibody Licensed to GlaxoSmithKline
10. Carrington Subsidiary DelSite Starts Making Test Batches of First Bird Flu Vaccine Offering Needle-free Self-Administration
11. NIH Funds Vaccine Research for Needle-free and Self-Administered Protection Against Pandemic Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)LIBREVILLE, Gabon, December 2 , - "Bolstering Biodiversity in Africa: Everyone,s Problem and Heritage" , Coinciding with the International Year of Biodiversity, 2-3 June 2010 the,Gabonese Rep
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)SHANGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is going through,extraordinary times; markets are in turmoil and uncertainty is part of many,businesses and industries. It turns out that the pharma ind
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
... LUVOX(R) CR Approved and Launched - Screening C...al, PALO ALTO, Calif., May 13 Jazz,Pharmaceutica...l results for,the quarter ended March 31, 2008., ...8 were $14.6 million,compared to $14.1 million for...m oxybate oral solution) net sales for the first q...
...upport for Grassley-Kohl Bill Newest Addition to L... Agenda, INDIANAPOLIS, May 13 Today Eli Lilly a...the newly revised Physicians,Payments Sunshine Act...sley,(R-Iowa) and Herbert Kohl (D-Wisconsin). The ...y of payments to physicians by medical device,medi...
...AKE FOREST, Ill., May 13 Hospira, Inc.,(NYSE: HS...ion delivery,company, announced today that Barbara... board of directors. Bowles brings strong investme...p positions held at major,multinational consumer g...s. The addition of Bowles expands Hospira,s board ...
Other Biology Technology:Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 2Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 3Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 4Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 5Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 6Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 7Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results 8Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians 2Lilly Backs Federal Legislation to Inform the Public on Payments to Physicians 3Hospira Expands Board of Directors 2
(Date:12/3/2009)ALBUQUERQUE, N.M. Most scientists believe that staph infections are caused by many bacterial cells that signal each other to emit toxins. The signaling process is called quorum sensing because many b
(Date:12/3/2009)Forest dwellers must be included in the design of the upcoming forest deal at Copenhagen in order to avoid a humanitarian crisis, according to a scientist at the University of Leeds. , Writing today
(Date:12/3/2009)The 30-year record low in Antarctic snowmelt that occurred during the 2008-09 austral summer was likely due to concurrent strong positive phases for two main climate drivers, ENSO (El Nio - Southern O
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2CCNY professor foresees rising Antarctic snowmelt 2Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 48037 1Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 48037 2Compressus Initiates Enterprise Workflow Management Implementation at Radiology Associates of Fox Valley 48037 3Senior Citizens Bureau Creates New Resourceful Divisions 48034 1Senior Citizens Bureau Creates New Resourceful Divisions 48034 2Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference 48033 1
...earch suggests that lowering cholesterol may block...t by Solomon et al, "Ezetimibe Is an Inhibitor of ...ue of The American Journal of Pathology . , High... heart disease, but may also contribute to cancer ...st common non-skin cancer in the United States, af...
... the human genome eight years ago, enormous progre.... Nevertheless, the function of most human genes i... in determining the function of a gene or protein ...undreds of other organisms that are experimentally...ted genes or proteins identified in these database...
...3, 2009 The legacy of nuclear weapons and nuclear...ment at dozens of sites across the United States a...anium. The uranium is transported through ground w...gy, uranium immobilization in contaminated ground ... of organic molecules known as electron donors to ...
Other Biology News:Lowering your cholesterol may decrease your risk of cancer 2Relationships in rank and file 2Relationships in rank and file 3Relationships in rank and file 4Patience pays off with methanol for uranium bioremediation 2
ImageQuant 300 from GE Healthcare, formerly Amersham Biosciences
Feline IL-12 / IL-23 p40, Unconjugated from R&D Systems
Rabbit Anti-ISOCITRATE DEHYDROGENASE Polyclonal Antibody, Unconjugated from AbD Serotec
... two highly efficient methods of identifying recom...consuming plasmid preparation. By using the large-...s to transfer partial colonies of E. coli bacteria...solutions provided by the kits and immediately run...
Biology Products: